EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
169 hedge funds and large institutions have $947M invested in Eagle Pharmaceuticals, Inc. in 2017 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 80 increasing their positions, 37 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
3% less funds holding
Funds holding: 175 → 169 (-6)
22% less capital invested
Capital invested by funds: $1.21B → $947M (-$264M)
Holders
169
Holding in Top 10
5
Calls
$7.68M
Puts
$5.85M
Top Buyers
| 1 | +$29.9M | |
| 2 | +$16.8M | |
| 3 | +$16.6M | |
| 4 |
LSV Asset Management
Chicago,
Illinois
|
+$13.6M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$12.7M |
Top Sellers
| 1 | -$217M | |
| 2 | -$49.2M | |
| 3 | -$15.9M | |
| 4 |
RIM
Ranger Investment Management
Dallas,
Texas
|
-$12.4M |
| 5 |
MCM
Matarin Capital Management
New York
|
-$8.16M |